Weight-loss drugs killed my appetite for life
Sam Altman, the co-founder of OpenAI, which launched ChatGPT, is not overweight. Gay tech billionaires rarely are. Even so, as he explained in a recent interview, he was keen to try a GLP-1, one of those drugs that have revolutionised weight loss in the past five years. You can understand why he was curious. Ozempic or Mounjaro might appear to have nothing in common with artificial intelligence, but both phenomena have created a sensation that we’re entering an era of accelerating and uncontrollable change. Alas, he screwed it up. He had someone inject him with a megadose, puked all night and then lay in bed for days ‘staring at a white ceiling thinking nothing’, not only feeling no urge to eat but also no ‘desire for anything’.
